title: Response: Is It Truly the Answer? Personalized Oxycodone Dosing Based on Pharmacogenetic Testing and Corresponding Pharmacokinetics.
authors.affiliation: Masters of Public Health Program Wayne State University School of Medicine Detroit, Michigan E-mail: olinare@med.wayne.edu.
authors.forename: Oscar A
authors.initials: OA
authors.lastname: Linares
authors.affiliation: Pharmacie Hôpital de la Croix-Rousse Hospices Civilis de Lyon, Lyon, France Laboratoire de Toxicologie ISPB, Université de Lyon, Lyon, France E-mail: michel.tod@chu-lyon.fr.
authors.forename: Michel
authors.initials: M
authors.lastname: Tod
authors.affiliation: US Medical Management Grace Hospice Troy, Michigan E-mail: adaly@usmmllc.com.
authors.forename: Annemarie L
authors.initials: AL
authors.lastname: Daly
authors.affiliation: Department of Biostatistics and Epidemiology Perelman School of Medicine University of Pennsylvania Philadelphia, Pennsylvania E-mail: DrRayBoston@yahoo.com.
authors.forename: Raymond C
authors.initials: RC
authors.lastname: Boston
mesh_terms: D000701:Analgesics, Opioid / Q000008:administration & dosage; D006801:Humans; D010098:Oxycodone / Q000008:administration & dosage*; D000071185:Pharmacogenomic Testing
chemical_list: D000701:Analgesics, Opioid; D010098:Oxycodone